Influence of polymeric blend of carbomer-gum on the targeted delivery of 5-FU

Polymer - Plastics Technology and Engineering

Volumn 48, Issue 12, 2009, Pages 1287-1294

  Sinha, V R ^a   Kumar, R V ^a,b   Bhinge, J R ^a,b  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

5 fluorouracil; Carbomer guar gum; Colon drug delivery; Enteric coated matrix tablets

Indexed keywords

5-FLUOROURACIL; CARBOMER-GUAR GUM; DRUG RELEASE; GUAR GUMS; HYDROPHILIC DRUGS; IN-VITRO; MATRIX TABLET; MICROENVIRONMENTS; NON-FICKIAN; POLYMERIC BLENDS; RELEASE MECHANISM; SITE-SPECIFIC; STABILITY STUDY; SWELLING STUDIES; TARGETED DELIVERY;

DRUG DELIVERY;

POLYMERS;

EID: 84866054166     PISSN: 03602559     EISSN: 15256111     Source Type: Journal    
DOI: 10.1080/03602550903204154     Document Type: Article

References (21)

1. Basit, A.W. Advances in colonic drug delivery. Drugs 2005, 65, 1991.
2. Kinget, R.; Kalale, W.; Vervoort, L.; Mooter, G.V. Colonic drug targeting. J. Drug Target. 1998, 6, 129-149.
3. nd Ed., Churchill Livingstone: New York, pp. 289-306, 2002.
4. Follonier, N.; Doelker, E. Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms. STP Pharm. Sci. 1992, 2, 141-155.
5. Sangalli, M.E.; Maroni, A.A.; Foppoli, L.; Zema, F.; Giordano, A.; Gazzaniga, A. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: a study on process parameters and in vitro performances. Eur. J. Pharm. Sci. 2004, 22, 469-476.
6. Pullan, R.D. Transdermal nicotine for active ulcerative colitis. N. Engl. J. Med. 1993, 330, 811-815.
7. Sandborn, W.J.; Rhodes, J. Colonic delivery of nicotine to treat inflammatory bowel disease. U.S. Patent 5846983, 1996.
8. Brock, M.H. Use of in vitro and in vivo data in the Design, development, and quality control of sustained-release decongestant dosage forms. Pharmacotherapy 1994, 14, 430-437.
9. Sinha, V.R.; Rachna, K. Polysaccharides in colon-specific drug delivery. Int. J. Pharm. 2004, 224, 19-38.
10. Beretta, G.D.; Milesi, L.; Pessi, M.A.; Mosconi, S.; Labianca, R. Adjuvant treatment of colorectal cancer. Surg. Oncol. 2004, 13, 63-73.
11. Ciftci, K.; Groves, M.J. Delivery of antitumor compounds to the rat colon: In vitro and in vivo evaluation. Int. J. Pharm. 1996, 145, 157-164.
12. Goto, T.; Tomizawa, N.; Kobayashi, F.; Fujimura, A. A comparative pharmacology study between the intracolonic and oral routes of 5-FU administration in a colon cancer-bearing Yoshida sarcoma rat model. J. Pharmacol. Sci. 2004, 95, 163-173.
13. United States Pharmacopoeia, 27th Edn. 2004. United States Pharmacopsoeial Convention Inc., Twin Brook Pathway. Rockville, MD 20852.
14. Sinha, V.R.; Mittal, B.R.; Bhutani, K.K.; Kumari, R. Colonic drug delivery of 5-Fluorouracil: An in-vitro evaluation. Int. J. Pharm.2004, 269, 101-108.
15. Higuchi, T. Rate of release of medications from ointment bases containing drugs in suspension. J. Pharm. Sci. 1961, 50, 874-875.
16. Korsemeyer, R.W.; Gurny, R.; Doelker, E.; Buri, P.; Peppas, N.A. Mechanisms of potasssiun chloride release from compressed, hydrophilic, polymeric matrices: Effect of entrapped air. J. Pharm. Sci. 1983, 72, 1189-1191.
17. Hixon, A.W.; Crowell, J.H. Dependence of reaction velocity upon surface and agitation. Ind. Eng. Chem. 1931, 23, 923-931.
18. Scott, R.A.; Cole, E.T. Enteric and colonic delivery using HPMC capsules. U.S. Patent 7094725, 2006.
19. Siepmann, J.; Kranz, H.; Bodmeier, R. A new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics. Pharm Res. 1999, 16, 1748-1756.
20. Kibbe, A.H. Handbook of Pharmaceutical Excipients, 3rd Ed. Pharmaceutical Press, United Kingdom. 2000, 79-82.
21. Ishibashi, T.; Hatano, H.; Kobayashi, M.; Mizone, M.; Yoshino, M. Design and evaluation of a new capsule-type dosage form for colon-targeted delivery of drugs. Int. J. Pharm. 1998, 168, 31-40.